In Russia, medical personnel have conducted more than 126 million tests for COVID-19, reports on Monday, April 19, the press service of Rospotrebnadzor.
“More than 126 million coronavirus tests have been carried out in the Russian Federation,” the statement said.
According to the department, over the past day, 263 thousand studies were carried out.
About 513.9 thousand people remain under medical supervision due to suspected COVID-19.
Earlier on the same day, it became known that the Avivir company, which is a resident of Skolkovo, and the Rapid BIO company registered the first rapid test in Russia to detect antibodies in the patient’s blood after immunization against coronavirus. vaccination and after. In addition, the test is capable of detecting persistent IgG antibodies that arise after an illness.
On April 15, it was reported that specialists from the Pasteur Research Institute of Epidemiology and Microbiology of Rospotrebnadzor developed and registered the first in Russia enzyme-linked immunosorbent assay for the quantitative determination of antibodies in the blood to coronavirus. The test is designed to determine the quantitative presence of antibodies in the blood to the SARS-CoV-2 coronavirus in persons infected with it and with clinical signs of COVID-19, including those who have had a history of illness or have been in contact with the coronavirus in the past without symptoms.